نتائج البحث - "Biphenyl Compounds* / adverse effects"

1

دورية أكاديمية

A Randomized, Double-blind, Active-controlled, Two Parallel-Group, Optional Titration, Multicenter, Phase IIIb Study to Evaluate the Efficacy and Safety of Fimasartan Versus Perindopril Monotherapy With and Without a Diuretic Combination in Elderly Patients With Essential Hypertension

المساهمون: Hae-Young Lee, Kwang-Il Kim, Sang Hyun Ihm, Moo-Yong Rhee, Il Suk Sohn, Sungha Park, Eun-Seok Jeon, Jong-Min Song, Wook Bum Pyun, Ki-Chul Sung, Moo Hyun Kim, Sang-Hyun Kim, Seok-Yeon Kim, Shin-Jae Kim, Eung Ju Kim, Jinho Shin, Sung Yun Lee, Kook-Jin Chun, Jin-Ok Jeong, Shung Chull Chae, Ki Dong Yoo, Young Jin Choi, Yong Hwan Park, Cheol-Ho Kim, Park, Sung Ha

العلاقة: CLINICAL THERAPEUTICS; J00614; OAK-2022-04453; https://ir.ymlib.yonsei.ac.kr/handle/22282913/190570Test; https://www.sciencedirect.com/science/article/pii/S0149291821003003Test; T202126182; CLINICAL THERAPEUTICS, Vol.43(10) : 1746-1756, 2021-10

الإتاحة: https://doi.org/10.1016/j.clinthera.2021.08.003Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/190570Test
https://www.sciencedirect.com/science/article/pii/S0149291821003003Test

View record in BASE

2

دورية أكاديمية

The efficacy and safety of co-administration of fimasartan and rosuvastatin to patients with hypertension and dyslipidemia

المساهمون: College of Medicine, Dept. of Internal Medicine, Moo-Yong Rhee, Taehoon Ahn, Kiyuk Chang, Shung Chull Chae, Tae-Hyun Yang, Wan Joo Shim, Tae Soo Kang, Jae-Kean Ryu, Deuk-Young Nah, Tae-Ho Park, In-Ho Chae, Seung Woo Park, Hae-Young Lee, Seung-Jea Tahk, Young Won Yoon, Chi Young Shim, Dong-Gu Shin, Hong Seog Seo, Sung Yun Lee, Doo Il Kim, Jun Kwan, Seung-Jae Joo, Myung Ho Jeong, Jin-Ok Jeong, Ki Chul Sung, Seok Yeon Kim, Sang-Hyun Kim, Kook-Jin Chun, Dong Joo Oh, Shim, Chi Young, Yoon, Young Won

مصطلحات موضوعية: Adult, Aged, Angiotensin II Type 1 Receptor Blockers/administration & dosage, Angiotensin II Type 1 Receptor Blockers/adverse effects, Angiotensin II Type 1 Receptor Blockers/therapeutic use, Anticholesteremic Agents/administration & dosage, Anticholesteremic Agents/adverse effects, Anticholesteremic Agents/therapeutic use, Biphenyl Compounds/administration & dosage, Biphenyl Compounds/adverse effects, Biphenyl Compounds/therapeutic use, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Hypercholesterolemia/complications, Hypercholesterolemia/drug therapy, Hypertension/complications, Hypertension/drug therapy, Male, Middle Aged, Pyrimidines/administration & dosage, Pyrimidines/adverse effects, Pyrimidines/therapeutic use, Rosuvastatin Calcium/administration & dosage, Rosuvastatin Calcium/adverse effects, Rosuvastatin Calcium/therapeutic use, Tetrazoles/administration & dosage, Tetrazoles/adverse effects

العلاقة: BMC PHARMACOLOGY & TOXICOLOGY; J03069; 2012; OAK-2017-00257; https://ir.ymlib.yonsei.ac.kr/handle/22282913/154111Test; T201700117; BMC PHARMACOLOGY & TOXICOLOGY, Vol.18(2) : 1-11, 2017

الإتاحة: https://doi.org/10.1186/s40360-016-0112-7Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/154111Test

View record in BASE

النص الكامل

3

دورية أكاديمية

Clinic and Home Blood Pressure Lowering Effect of an Angiotensin Receptor Blocker, Fimasartan, in Postmenopausal Women with Hypertension.

المساهمون: College of Medicine, Dept. of Internal Medicine, Song-Yi Kim, Seung-Jae Joo, Mi-Seung Shin, Changsoo Kim, Eun Joo Cho, Ki-Chul Sung, Seok-Min Kang, Dong-Soo Kim, Seung Hwan Lee, Kyung-Kuk Hwang, Jeong Bae Park, Kang, Seok Min, Kim, Chang Soo

وصف الملف: application/pdf

العلاقة: MEDICINE; J02214; OAK-2016-03325; https://ir.ymlib.yonsei.ac.kr/handle/22282913/147145Test; T201602211; MEDICINE, Vol.95(22) : 3764, 2016

الإتاحة: https://doi.org/10.1097/MD.0000000000003764Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/147145Test

View record in BASE

النص الكامل

4

دورية أكاديمية

A Randomized, Double-blind, Candesartan-controlled, Parallel Group Comparison Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Patients with Mild to Moderate Essential Hypertension.

المساهمون: College of Medicine, Dept. of Internal Medicine, Jang Hoon Lee, Dong Heon Yang, Jin Yong Hwang, Seung Ho Hur, Tae Joon Cha, Ki-Sik Kim, Moo Hyun Kim, Kook Jin Chun, Gwang Soo Cha, Geu Ru Hong, Sang Gon Lee, Dong Soo Kim, Doo Il Kim, Shung Chull Chae, Hong, Geu Ru

مصطلحات موضوعية: Adult, Aged, Angiotensin II Type 1 Receptor Blockers/adverse effects, Angiotensin II Type 1 Receptor Blockers/therapeutic use, Antihypertensive Agents/adverse effects, Antihypertensive Agents/therapeutic use, Benzimidazoles/adverse effects, Benzimidazoles/therapeutic use, Biphenyl Compounds/adverse effects, Biphenyl Compounds/therapeutic use, Blood Pressure/drug effects, Dose-Response Relationship, Drug, Double-Blind Method, Essential Hypertension, Female, Humans, Hypertension/drug therapy, Hypertension/physiopathology, Male, Middle Aged, Pyrimidines/adverse effects, Pyrimidines/therapeutic use, Tetrazoles/adverse effects, Tetrazoles/therapeutic use, Young Adult, angiotensin receptor blocker, candesartan, fimasartan, hypertension

وصف الملف: 1485~1497

العلاقة: CLINICAL THERAPEUTICS; J00614; OAK-2016-03345; https://ir.ymlib.yonsei.ac.kr/handle/22282913/147150Test; http://www.sciencedirect.com/science/article/pii/S0149291816302399Test; T201602235; CLINICAL THERAPEUTICS, Vol.38(6) : 1485-1497, 2016

الإتاحة: https://doi.org/10.1016/j.clinthera.2016.04.005Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/147150Test
http://www.sciencedirect.com/science/article/pii/S0149291816302399Test

View record in BASE

5

دورية أكاديمية

Efficacy and Safety of 30-Mg Fimasartan for the Treatment of Patients With Mild to Moderate Hypertension: An 8-Week, Multicenter, Randomized, Double-Blind, Phase III Clinical Study

المساهمون: Jong Chan Youn, Sang Hyun Ihm, Jang Ho Bae, Seong Mi Park, Dong Woon Jeon, Byung Chun Jung, Tae Ho Park, Nae Hee Lee, Jong Min Song, Young Won Yoon, Eun Seok Shin, Ki Chul Sung, In Hyun Jung, Wook Bum Pyun, Seung Jae Joo, Woo Jung Park, Jin Ho Shin, Seok Min Kang, Kang, Seok Min, Yoon, Young Won, Youn, Jong Chan

وصف الملف: 1412~1421

العلاقة: CLINICAL THERAPEUTICS; J00614; OAK-2014-03010; https://ir.ymlib.yonsei.ac.kr/handle/22282913/138743Test; http://www.sciencedirect.com/science/article/pii/S0149291814004391Test; T201405549; CLINICAL THERAPEUTICS, Vol.36(10) : 1412-1421, 2014

الإتاحة: https://doi.org/10.1016/j.clinthera.2014.07.004Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/138743Test
http://www.sciencedirect.com/science/article/pii/S0149291814004391Test

View record in BASE

6

دورية أكاديمية

Influence of Hepatic Dysfunction on the Pharmacokinetics and Safety of Fimasartan

المساهمون: Choon Ok Kim, Hae Wan Lee, Eun Sil Oh, Sook Jin Seong, Do Young Kim, Joomi Lee, Sang-Hoon Ahn, Young-Ran Yoon, Chang-Min Cho, Min Soo Park, Kim, Do Young, Park, Min Soo, Ahn, Sang Hoon

مصطلحات موضوعية: Adult, Angiotensin II Type 1 Receptor Blockers/adverse effects, Angiotensin II Type 1 Receptor Blockers/blood, Angiotensin II Type 1 Receptor Blockers/pharmacokinetics, Antihypertensive Agents/adverse effects, Antihypertensive Agents/blood, Antihypertensive Agents/pharmacokinetics, Biological Availability, Biphenyl Compounds/adverse effects, Biphenyl Compounds/blood, Biphenyl Compounds/pharmacokinetics, Blood Pressure/drug effects, Half-Life, Heart Rate/drug effects, Hepatic Insufficiency/blood, Hepatic Insufficiency/metabolism, Hepatic Insufficiency/physiopathology, Humans, Liver/drug effects, Liver/physiopathology, Male, Metabolic Clearance Rate, Middle Aged, Pyrimidines/adverse effects, Pyrimidines/blood, Pyrimidines/pharmacokinetics, Republic of Korea, Severity of Illness Index, Tetrazoles/adverse effects, Tetrazoles/blood

العلاقة: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY; J01296; OAK-2013-03137; https://ir.ymlib.yonsei.ac.kr/handle/22282913/89251Test; http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00005344-201312000-00004&LSLINK=80&D=ovftTest; T201305833; JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, Vol.62(6) : 524-529, 2013

الإتاحة: https://doi.org/10.1097/FJC.0000000000000010Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/89251Test
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00005344-201312000-00004&LSLINK=80&D=ovftTest

View record in BASE

7

دورية أكاديمية

Phase IV, 8-week, multicenter, randomized, active treatment-controlled, parallel group, efficacy, and tolerability study of high-dose candesartan cilexetil combined with hydrochlorothiazide in Korean adults with stage II hypertension.

المساهمون: Hae-Young Lee, Bum-Kee Hong, Wook Jin Chung, Byoung Kwon Lee, Seung Hwan Lee, Dong Woon Jeon, Young Keun Ahn, Dooil Kim, Chang Kyu Park, Sang-Hyun Kim, Hae Ok Jung, Byung-Ok Kim, Donghoon Choi, Hong, Bum Kee, Lee, Byoung Kwon, Choi, Dong Hoon

مصطلحات موضوعية: Adult, Aged, Antihypertensive Agents/administration & dosage, Antihypertensive Agents/adverse effects, Antihypertensive Agents/therapeutic use, Asian Continental Ancestry Group, Benzimidazoles/administration & dosage, Benzimidazoles/adverse effects, Benzimidazoles/therapeutic use, Biphenyl Compounds/administration & dosage, Biphenyl Compounds/adverse effects, Biphenyl Compounds/therapeutic use, Blood Pressure/drug effects, Dizziness/chemically induced, Dose-Response Relationship, Drug, Drug Combinations, Female, Humans, Hydrochlorothiazide/administration & dosage, Hydrochlorothiazide/adverse effects, Hydrochlorothiazide/therapeutic use, Hypertension/drug therapy, Male, Middle Aged, Republic of Korea, Tetrazoles/administration & dosage, Tetrazoles/adverse effects, Tetrazoles/therapeutic use, Treatment Outcome